ALX Oncology Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for ALX Oncology Holdings (ALXO).

Price Target Range — 8 Quarters

Analyst Consensus — 7 Analysts

6Buy

1Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$4Upside to Avg. PT+224.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Mar 19, 2026	Wells Fargo	Derek Archila	Initiate	Overweight	$5
Mar 10, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$4
Feb 5, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$3→$4
May 21, 2025	UBS	Colin Bristow	PT Cut	Buy	$1→$1
May 9, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$5→$2
Mar 7, 2025	Stifel	Bradley Canino	PT Cut	Hold	$3→$2
Mar 7, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$5
Mar 6, 2025	Piper Sandler	Christopher Raymond	PT Raise	Overweight	$8→$9
Mar 6, 2025	Jefferies	Michael Yee	Upgrade	Hold→Buy	$2→$3
Jan 27, 2025	UBS	Colin Bristow	PT Cut	Buy	$4→$2
Jan 24, 2025	Cantor Fitzgerald	Li Watsek	Maintained	Overweight	—
Jan 24, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$25→$5
Dec 19, 2024	Jefferies	Michael Yee	Downgrade	Buy→Hold	$12→$2
Dec 18, 2024	Cantor Fitzgerald	Li Watsek	Maintained	Overweight	—
Dec 18, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$25
Nov 12, 2024	Cantor Fitzgerald	Li Watsek	Maintained	Overweight	—
Aug 16, 2024	UBS	Colin Bristow	PT Cut	Buy	$25→$4
Aug 13, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$25
Aug 12, 2024	Cantor Fitzgerald	Li Watsek	Maintained	Overweight	—
Aug 9, 2024	Stifel	Bradley Canino	PT Cut	Hold	$5→$3

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5

Wells Fargo analyst Derek Archila initiates coverage on ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight rating and announces Price Target of $5.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $4 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and maintains $4 price target.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $4

Piper Sandler analyst Allison Bratzel maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight and raises the price target from $3 to $4.

Benzinga Newsdesk

PRO
UBS Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $1

UBS analyst Colin Bristow maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers the price target from $1.2 to $1.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $2

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers the price target from $5 to $2.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on ALX Oncology Holdings, Lowers Price Target to $1.5

Stifel analyst Bradley Canino maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Hold and lowers the price target from $3 to $1.5.

Benzinga Newsdesk

ALX Oncology Holdings Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

ALX Oncology Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Wells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5

PRO
HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $4 Price Target

PRO
Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $4

PRO
UBS Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $1

PRO
HC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $2

PRO
Stifel Maintains Hold on ALX Oncology Holdings, Lowers Price Target to $1.5

People Also Watch

People Also Watch

ALX Oncology Holdings Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

ALX Oncology Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5

PROHC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $4 Price Target

PROPiper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $4

PROUBS Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $1

PROHC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $2

PROStifel Maintains Hold on ALX Oncology Holdings, Lowers Price Target to $1.5

People Also Watch

People Also Watch

PRO
Wells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5

PRO
HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $4 Price Target

PRO
Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $4

PRO
UBS Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $1

PRO
HC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $2

PRO
Stifel Maintains Hold on ALX Oncology Holdings, Lowers Price Target to $1.5